Christine Schuberth-Wagner

Title: Christine Schuberth-Wagner: Innovator in Biotechnology

Introduction

Christine Schuberth-Wagner is a prominent inventor based in Siegburg, Germany. She has made significant contributions to the fields of biotechnology and pharmaceuticals. With a total of 5 patents to her name, her work focuses on the development of RIG-I ligands, which have important applications in medical research.

Latest Patents

Her latest patents include a method for designing RIG-I ligands. This invention identifies potent RIG-I agonists through a specific sequence motif. The method is directed towards producing RIG-I agonists, which are crucial for various therapeutic applications. Another notable patent involves new triphosphate-modified oligonucleotides that act as RIG-I ligands. This invention also includes a novel method for synthesizing and purifying these ligands in high yield and purity, making them suitable for pharmaceutical use.

Career Highlights

Christine has worked with esteemed institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Rigontec GmbH. Her research has significantly advanced the understanding of RIG-I pathways and their potential therapeutic uses.

Collaborations

Some of her notable coworkers include Marion Goldeck and Jasper Van Den Boorn. Their collaborative efforts have contributed to the success of her research projects.

Conclusion

Christine Schuberth-Wagner's innovative work in biotechnology continues to pave the way for advancements in pharmaceutical applications. Her contributions to the field are invaluable and highlight the importance of research in developing new therapeutic strategies.